Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Optimi Health Corp (OPTI.CN)

Optimi Health Corp (OPTI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 18,459
  • Shares Outstanding, K 94,663
  • Annual Sales, $ 181 K
  • Annual Income, $ -5,195 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.47
  • Price/Sales 69.89
  • Price/Cash Flow N/A
  • Price/Book 1.64

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1800 +30.56%
on 10/29/24
0.2450 -4.08%
on 10/16/24
+0.0050 (+2.17%)
since 10/04/24
3-Month
0.1800 +30.56%
on 10/29/24
0.3800 -38.16%
on 08/09/24
-0.0900 (-27.69%)
since 08/06/24
52-Week
0.1500 +56.67%
on 12/12/23
0.5800 -59.48%
on 01/03/24
+0.0750 (+46.87%)
since 11/06/23

Most Recent Stories

More News
Optimi Health Announces First PTSD Patients Treated with MDMA Capsules in Australia

Additional 700 Doses Ordered by Mind Medicine Australia as Demand SurgesVancouver, British Columbia--(Newsfile Corp. - October 23, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi"...

OPTI.CN : 0.2350 (+20.51%)
OPTHF : 0.1570 (+8.28%)
Optimi Health Announces Leadership Transition

Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed manufacturer...

OPTI.CN : 0.2350 (+20.51%)
OPTHF : 0.1570 (+8.28%)
Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial

Trial to study Major Depressive Disorder using Optimi's GMP natural psilocybin capsules in conjunction with therapyVancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Optimi Health Corp....

OPTHF : 0.1570 (+8.28%)
OPTI.CN : 0.2350 (+20.51%)
Optimi Health Completes Inaugural Export of MDMA Capsules to Australia for PTSD Treatment

Vancouver, British Columbia--(Newsfile Corp. - August 16, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada-licensed psychedelics...

OPTHF : 0.1570 (+8.28%)
OPTI.CN : 0.2350 (+20.51%)
Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development

Vancouver, British Columbia and New York, New York--(Newsfile Corp. - August 13, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi"), a GMP-approved, Health Canada licensed psychedelics...

PBM : 0.0619 (-5.78%)
OPTHF : 0.1570 (+8.28%)
OPTI.CN : 0.2350 (+20.51%)
Optimi Health Announces Non-Brokered Private Placement

Vancouver, British Columbia--(Newsfile Corp. - August 7, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics...

OPTHF : 0.1570 (+8.28%)
OPTI.CN : 0.2350 (+20.51%)
Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research

Observational studies to focus on patients with addiction and end-of-life distress pending formal approval and permitting from Thai health authoritiesVancouver, British Columbia--(Newsfile Corp. - July...

OPTHF : 0.1570 (+8.28%)
OPTI.CN : 0.2350 (+20.51%)
Optimi Health and Mind Medicine Australia Launch OptiMed Prescriber Portal for Australian Psychiatrists

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-approved, GMP-compliant pharmaceutical...

OPTHF : 0.1570 (+8.28%)
OPTI.CN : 0.2350 (+20.51%)
Health Canada Issues Three Export Permits to Optimi to Supply Patients Under Australia's Authorised Prescriber Scheme

The Company will ship 160 doses of MDMA and psilocybin to Australian psychiatrists for the treatment of patients with PTSD and Treatment-Resistant Depression.Vancouver, British Columbia--(Newsfile Corp....

OPTHF : 0.1570 (+8.28%)
OPTI.CN : 0.2350 (+20.51%)
Optimi Health Completes First International Shipment of MDMA to Israel and Secures CBSA Exporters Authorization ID

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a leading Health Canada licensed GMP psychedelics...

OPTHF : 0.1570 (+8.28%)
OPTI.CN : 0.2350 (+20.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate,...

See More

Key Turning Points

3rd Resistance Point 0.2183
2nd Resistance Point 0.2117
1st Resistance Point 0.2033
Last Price 0.2350
1st Support Level 0.1883
2nd Support Level 0.1817
3rd Support Level 0.1733

See More

52-Week High 0.5800
Fibonacci 61.8% 0.4157
Fibonacci 50% 0.3650
Fibonacci 38.2% 0.3143
Last Price 0.2350
52-Week Low 0.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar